AU2001268884A1 - Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections - Google Patents

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Info

Publication number
AU2001268884A1
AU2001268884A1 AU2001268884A AU6888401A AU2001268884A1 AU 2001268884 A1 AU2001268884 A1 AU 2001268884A1 AU 2001268884 A AU2001268884 A AU 2001268884A AU 6888401 A AU6888401 A AU 6888401A AU 2001268884 A1 AU2001268884 A1 AU 2001268884A1
Authority
AU
Australia
Prior art keywords
inhibiting
preventing
papilloma virus
cellulose sulfate
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268884A
Inventor
Robert A Anderson
Thomas C Usher
Lourens J. D. Zaneveld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polydex Pharmaceuticals Ltd
Rush Presbyterian St Lukes Medical Center
Original Assignee
POLYDEX PHARMA
Polydex Pharmaceuticals Ltd
Rush Presbyterian St Lukes Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POLYDEX PHARMA, Polydex Pharmaceuticals Ltd, Rush Presbyterian St Lukes Medical Center filed Critical POLYDEX PHARMA
Publication of AU2001268884A1 publication Critical patent/AU2001268884A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention relates to the treating, inhibiting or preventing of certain infectious agents including papilloma virus and various vaginitis-causing microbes by employing cellulose sulfate and other sulfated polysaccharides. In one embodiment, the method involves preventing, inhibiting or treating fungal infections. Corresponding methods of use in manufacturing a medicament as well as use in preventing and inhibiting various infectious agents as well as malignant lesions are disclosed. In another embodiment, use of a sulfated polysaccharide in preventing, inhibiting or treating a parasitic infection is disclosed.
AU2001268884A 2000-06-30 2001-06-29 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections Abandoned AU2001268884A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21532500P 2000-06-30 2000-06-30
US60/215,325 2000-06-30
PCT/CA2001/000964 WO2002002189A2 (en) 2000-06-30 2001-06-29 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Publications (1)

Publication Number Publication Date
AU2001268884A1 true AU2001268884A1 (en) 2002-01-14

Family

ID=22802531

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268884A Abandoned AU2001268884A1 (en) 2000-06-30 2001-06-29 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

Country Status (9)

Country Link
US (3) US7078392B2 (en)
EP (1) EP1296691B1 (en)
AT (1) ATE308329T1 (en)
AU (1) AU2001268884A1 (en)
CA (1) CA2414320C (en)
DE (1) DE60114620T2 (en)
DK (1) DK1296691T3 (en)
ES (1) ES2253395T3 (en)
WO (1) WO2002002189A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003023045A1 (en) * 2001-09-06 2003-03-20 Techno Network Shikoku Co.,Ltd. Sulfated polysaccharides, process for producing the same and substances having the same as the active ingredient
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005108098A (en) * 2003-10-01 2005-04-21 Hitachi Ltd Data i/o device and control method of data i/o device
TW200632316A (en) * 2004-12-17 2006-09-16 Bayer Healthcare Llc Disposable test sensor cartridge
EP2007401A2 (en) * 2006-04-04 2008-12-31 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
EP1842546B1 (en) * 2006-04-04 2009-03-11 Marinomed Biotechnologie GmbH Cellulose sulfate for the treatment of rhinovirus infection
US20100055060A1 (en) * 2006-11-27 2010-03-04 Naoyuki Yoshida Cosmetic composition
US20080131454A1 (en) 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
JP2008266265A (en) * 2007-04-24 2008-11-06 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Antiviral agent
KR101571571B1 (en) 2007-08-24 2015-11-24 마리노메드 바이오테크놀로지 게엠베하 Antiviral composition comprising a sulfated polysaccharide
US20090118352A1 (en) * 2007-11-07 2009-05-07 Esawtech, Ltd. Broad spectrum microbicidal and spermicidal compositions and methods
US8501214B2 (en) * 2007-11-26 2013-08-06 Modetex Biomedical Materials & Technology Industrial Corp. Hydrophilic foam and pharmaceutical dosage form employing the same
JP5702526B2 (en) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 Fiber assembly carrying sulfated cellulose having antiviral properties
TWI401096B (en) * 2009-12-31 2013-07-11 Pharmaceutical dosage form for treating, managing or preventing vaginal infections or cervical cancer and gel composition and hydrophilic foam comprised therein
MD4110C1 (en) * 2010-10-21 2011-12-31 Валериу РУДИК Antiherpetic preparation
FR2989001B1 (en) 2012-04-06 2017-07-21 Centre Nat Rech Scient MICROPARTICLES AND NANOPARTICLES COMPRISING HYDROPHOBIC POLYSACCHARIDES AND ALPHA-CYCLODEXTRIN
FR2998176B1 (en) * 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii POLYSACCHARIDE SULFATE COMPOSITION
WO2014147287A1 (en) 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound
EP3204016B1 (en) 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Compositions comprising sulfated polysaccharides and uses thereof
CN105748506B (en) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 Application of the alginic acid sulfuric ester in the drug and health products for preparing prevention and treatment disease caused by Subclinical papillomavirus infection
EP3939597A1 (en) * 2020-07-16 2022-01-19 Marinomed Biotech AG Antiviral pharmaceutical composition comprising a carrageenan component

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70511A (en) 1982-12-28 1990-01-18 Anic Spa Process for the concurrent depolymerization and sulfation of polysaccharides at hydroxyl groups
FR2542616B1 (en) * 1983-03-17 1987-07-31 Unilever Nv COMPOSITION FOR THE TREATMENT OF MUCOSA BASED ON AN ANTIBIOTIC AND A GEL-FORMING HYDROCOLLOID
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
DE3851386T2 (en) 1987-07-07 1995-03-30 Ajinomoto Kk Use of glycans as antiviral compounds.
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
EP0402078A3 (en) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexual lubricants containing zinc as an anti-viral agent
AU1052492A (en) 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
EP0664700A1 (en) 1992-10-13 1995-08-02 Otsuka America Pharmaceutical, Inc. Treatment of cachexia and inhibition of il-6 activity
WO1995008334A1 (en) * 1993-09-20 1995-03-30 Ajinomoto Co., Inc. Antimalarial
US6063773A (en) 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US6239182B1 (en) 1995-10-13 2001-05-29 Rush-Presbyterian-St. Lukes Medical Center Method for preventing sexually transmitted diseases
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5955096A (en) * 1996-06-25 1999-09-21 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US5853767A (en) 1997-01-02 1998-12-29 Melman; Steven A. Compositions for treating fungal, parasitic and/or bacterial infections, especially infections of organs such as the skin and vagina
JPH1180003A (en) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd Agent for preventing and treating infectious disease

Also Published As

Publication number Publication date
US20030181415A1 (en) 2003-09-25
ATE308329T1 (en) 2005-11-15
DK1296691T3 (en) 2006-03-20
US7235536B2 (en) 2007-06-26
US20050203055A1 (en) 2005-09-15
CA2414320A1 (en) 2002-01-10
ES2253395T3 (en) 2006-06-01
US7078392B2 (en) 2006-07-18
DE60114620T2 (en) 2006-07-27
US20050143342A1 (en) 2005-06-30
CA2414320C (en) 2008-04-01
WO2002002189A3 (en) 2002-09-19
EP1296691B1 (en) 2005-11-02
DE60114620D1 (en) 2005-12-08
EP1296691A2 (en) 2003-04-02
WO2002002189A2 (en) 2002-01-10
US7226914B2 (en) 2007-06-05

Similar Documents

Publication Publication Date Title
AU2001268884A1 (en) Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
AU2001275651A1 (en) Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
WO2003057135A3 (en) Aqueous compositions containing metronidazole
WO2005046618A3 (en) Methods of treating eczema
DE69829690D1 (en) IMPROVED WUNDAUFLAGEN
ATE508735T1 (en) PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
NO954996L (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
BR0109165A (en) Cholemic polyps treatment method
EP1576963A3 (en) Use of botulinum toxin in the treatment of pain due to an infection
WO2006032500A3 (en) Immunogenic composition
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
AU2079901A (en) Thrombopoietin mimetics
DE60041753D1 (en) MEDICAMENT FOR THE TREATMENT OF C. PNEUMONIAE INFECTIONS
PT1368041E (en) AQUOSA COMPOSITION OF ANFOTERICINE
BR0114449A (en) Chitosan-containing cleaning compositions
DE60332112D1 (en) TOPICAL APPLICATION OF AT LEAST ONE DOUBLE-STRUCTURED RNA OLIGONUCLEOTIDE (DS RNA) AGAINST TYROSINASE
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
BR0008712A (en) Echinocandin / carbohydrate complexes
WO2002040001A3 (en) Compositions for treatment of malignant effusions comprising a biocompatible polymer and antineoplastic taxane
WO2002049633A3 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
BR0010699A (en) Substituted benzimidazoles, their production and use as an agent against parasitic protozoa
EP1408941A4 (en) Pharmaceutical composition and method of using the same
EP1557170A3 (en) Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections